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Emerging evidence indicates that epidermal growth factor (EGF) signaling plays a
positive role in myelin development and repair, but little is known about its biological
effects on the early generation and differentiation of oligodendrocyte (OL) lineage cells.
In this study, we investigated the role of EGF in early OL development with isolated glial
restricted precursor (GRP) cells. It was found that EGF collaborated with Platelet Derived
Growth Factor-AA (PDGFaa) to promote the survival and self-renewal of GRP cells,
but predisposed GRP cells to develop into O4− early-stage oligodendrocyte precursor
cells (OPCs) in the absence of or PDGFaa. In OPCs, EGF synergized with PDGFaa
to maintain their O4 negative antigenic phenotype. Upon PDGFaa withdrawal, EGF
promoted the terminal differentiation of OPCs by reducing apoptosis and increasing the
number of mature OLs. Together, these data revealed that EGF is an important mitogen
to enhance oligodendroglial development.
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INTRODUCTION
Oligodendrocytes (OLs) elaborate insulating myelin sheaths that wrap around axons to ensure the
rapid conduction of nerve impulses and axonal survival (Qiu, 2013; Zhang et al., 2013; Blank and
Prinz, 2014; Alizadeh et al., 2015; Rao and Pearse, 2016). Tripotential glial-restricted precursor
(GRP) cells were initially found in embryonic spinal tissues (Herrera et al., 2001; Gregori et al., 2002;
Wu et al., 2002; Cao et al., 2005; Phillips et al., 2012), as they can generate OLs and type I and type II
astrocytes in vitro (Rao et al., 1998; Gregori et al., 2002; Yang et al., 2016) and in vivo (Herrera et al.,
2001; Hill et al., 2004). The germination of GRP cells from neuroepithelial stem cells was viewed as
the beginning of OL generation (Rao et al., 1998; Gregori et al., 2002). Tripotential GRP cells then
generate bipotential oligodendrocyte precursor cells (OPCs) which are capable of differentiating
into either OLs or type II astrocytes (Morath and Mayer-Pröschel, 2001; Gregori et al., 2002).
OPCs proliferate and migrate throughout the CNS during late mouse embryonic development,
and later differentiate into mature myelinating OLs (Fernandez et al., 2004; Cai et al., 2010;
Chen et al., 2015).
Emerging evidence suggests that epidermal growth factor (EGF) signaling plays an important
role in oligodendroglial development (Aguirre et al., 2007; Chong et al., 2008; Hu et al., 2010).
Abbreviations: bFGF, Basic fibroblast growth factor; EGF, Epidermal growth factor; EGFR, Epidermal growth factor
receptor; GRP, Glial restricted precursor; OL, Oligodendrocyte; OPC, Oligodendrocyte precursor cells; PDGFaa,
Platelet derived growth factor-AA.
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Loss-of-function of epidermal growth factor receptor
(EGFR) reduced oligodendrogenesis in vivo (Aguirre
et al., 2007); conversely, intraventricular infusion of EGF
induced subventricular zone (SVZ) type B cells to migrate
and differentiate into OLs (Gonzalez-Perez et al., 2009).
More recently, it was shown that intranasal EGF treatment
immediately after brain injury promoted oligodendrogenesis
and remyelination (Scafidi et al., 2014). Although the
importance of EGF signaling in the development of OL
lineage has been established, it remains elusive at what stage of
oligodendrogenesis EGF starts to function and how it regulates
the development of OL lineage progression.
In this study, we used mouse GRP cells as the starting point
to systematically investigate the role of EGF signaling in OL
lineage development. It was found that cells of OL lineage were
responsive to EGF at all developmental stages. In GRP cells, EGF
promoted their proliferation and survival by augmenting their
responsiveness to Platelet Derived Growth Factor-AA (PDGFaa)
for self-renewal. In the absence of PDGFaa, EGF predisposed
GRP cells to differentiate into O4− early-stage OPCs. At OPC
stage, EGF collaborated with PDGFaa to enhance OPC self-
renewal. Upon PDGFaa withdrawal, OPCs underwent terminal
differentiation and EGF functioned to reduce apoptosis and
increase the number of mature OLs.
MATERIALS AND METHODS
Isolation and Culture of GRP Cells
GRP cells were isolated from E13.5 C57BL/6 mouse spinal
cord by A2B5 immunopanning as described elsewhere (Gregori
et al., 2002), all experimental procedures were carried out in
accordance with institutional guidelines for the care and use
of laboratory animals, and the protocol was approved by the
Animal Ethics Committee of Hangzhou Normal University,
China. A2B5+ cells were then grown in glial basal medium
(DMEM/F12, 1 × N2, 1 × B27, 1 × P/S, and 0.1% w/v BSA,
all from Gibco) supplemented with 10 ng/ml PDGFaa and
EGF (Peprotech) on fibronectin/laminin coated 12-well plates at
2000 cells/well for mass culture experiments or on coated 24-well
plated at 1000 cells/well for immunofluorescence staining. The
immunostaining was performed 3 days after seeding using the
standard protocols.
Clonal Analysis and Sub-Cloning of GRP
Cells
Immunopurified A2B5+ cells from E13.5 spinal tissues were
adjusted to a cell density of 10 cells/ml with glial basal medium
supplemented with 10 ng/ml EGF and PDGFaa, then the cell
suspension was added into fibronectin/laminin-coated 96-well
plates at 100 µl/well, and wells with a single cell were marked
for further culture. When primary clones were generated, 10
clones were randomly selected and only one was found to be
A2B5 negative. Of the nine A2B5+ clones, three were subjected
to differentiation potential analysis as indicated in the "Results"
Section. The other six A2B5+ clones were used for sub-cloning
analysis. Each clone was replated on three separate grid dishes at
equal clonal density, and cultured in presence of EGF, PDGFaa or
both. After 6 days, the numbers of secondary clones were scored.
Cell Proliferation and Apoptosis Analysis
For cell proliferation and apoptosis analysis, 1 × 104 cells were
plated to each fibronectin/laminin-coated 24-well plates. Cell
proliferation was analyzed by adding BrdU (Sigma) to a final
concentration of 30 ng/ml. Following 24 h of incorporation, cells
were fixed in 4% paraformaldehyde at RT for 10 min, and BrdU
positive cells were detected by anti-BrdU immunostaining. For
apoptosis assays, cells were fixed in 4% paraformaldehyde 3 days
after replating and apoptotic cells were detected by TUNEL
FITC Apoptosis Detection Kit (Vazyme Biotech). Positive cells
were counted from three different areas of each well under
fluorescence microscopy. The results were expressed as mean
values and standard deviation.
GRP Cell Development
The function of EGF on the development of GRP cells into
OPCs was confirmed by single-cell tracking clonal differentiation
analysis as described previously (Gregori et al., 2002). Freshly
immunopurified GRP cells from E13.5 spinal tissues were
adjusted to a cell density of 10 cells/ml with glial basal
medium supplemented, then the cell suspension was added into
fibronectin/laminin-coated 48-well plates at 100 µl/well in the
presence of EGF and PDGFaa (10 ng/ml) for 24 h before being
exposed to the factors as indicated in the "Results" Section wells
with a single cell were marked for further culture. Since there
is no specific immunological marker to distinguish GRP cells
from OPCs, one candidate marker for distinguishing them is
the O4 monoclonal antibody, which labels late-stage OPCs and
OLs (Gard and Pfeiffer, 1990; Bansal et al., 1992). Therefore, the
proportion of O4+ cells was used as a standard to estimate the
differentiation of GRP cells.
OPC Culture
O4− early-stage OPCs were induced from GRP cells and plated
on the fibronectin/laminin-coated plates and fed every other day
with glial basal medium supplemented with EGF and PDGFaa.
Because of the presence of contact inhibition, OPCs were plated
more sparsely than GRP cells, and passaged more frequently.
OPCs were plated at 1500 cells/cm2 for mass culture, and
750 cells/cm2 for differentiation experiments due to process
growth.
Western Immunoblotting
Western blotting was carried out as previously described (Yang
et al., 2009). Briefly, cells were lysed in sample buffer plus
a cocktail of protease inhibitors (Roche). For each sample,
20 µg of protein was used for electrophoresis in SDS-PAGE gel.
Primary antibodies were used as follows; anti-rabbit PDGFRα
(1:1000, Santa Cruz), anti- rabbit EGFR (1:200, Abcam), anti-
rabbit Olig2 (1:1000, Millipore), anti-rabbit Nestin (1:5000,
Covance) and anti-mouse MBP (1:1000, Abcam). Horseradish
peroxidase (HRP)-conjugated secondary antibody (Promaga)
was used at 1:2500. Chemiluminescent signals were detected by
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autoradiography using the ECL System (Amersham, Piscataway,
NJ, USA).
Immunocytochemical Analysis
Immunocytochemical analysis was carried out as previously
described (Cheng et al., 2017). Antibodies used include
anti-mouse A2B5 IgM, anti-BrdU IgM, O4 IgM (1:1 dilution in
DPBS + 10% goat serum), anti-mouse Olig2 (1:1000, Millipore),
anti-mouse MBP (1:500, Abcam), anti- rabbit EGFR (1:200,
Abcam), anti-mouse GFAP (1:300, Chemicon), anti-rabbit
Nestin (1:2000, Covance), and anti-rabbit neurofilament (1:100,
Sigma). The Alexa-488 or Alexa-594 conjugated secondary
antibodies were obtained from Molecular Probes (Thermo
fisher). The nucleic acid dye 4′,6-diamidino-2-phenylindole
(DAPI) was obtained from Roche.
Statistical Analysis
All quantitative data are presented as means ± SD. Statistical
significance of the difference was evaluated by Student’s t-test.
P-value< 0.05 was considered statistically significant.
RESULTS
EGF Enhances the Survival and Extensive
Self-Renewal of GRP Cells in Culture
To investigate the role of EGF on OL lineage development,
we first immunopurified A2B5+ cells from E13.5 spinal cord
tissues (Liu et al., 2002). These A2B5+ cells expressed typical
GRP markers including PDGFRα (Rao et al., 1998), Olig2
(Zhao et al., 2009) and Nestin (Yoo and Wrathall, 2007;
Figures 1A–D,I–Q), but not neuronal marker neurofilament
(Tang et al., 2007; Rao and Pearse, 2016) and astrocyte marker
GFAP (Sun et al., 2008; Sántha et al., 2016). The GRP cells were
also immunoreactive for EGFR (Figures 1E–H,Q) suggesting
their potential EGF-responsiveness. The effects of EGF on
A2B5+ cell proliferation were investigated in culture exposed
to different concentrations of EGF (0, 2.5, 5, 10, 20 and
40 ng/ml) for 24 h. BrdU labeling revealed a dose-dependent
effect on cell division at the concentration range of 0–10 ng/ml
(Figure 2A). However, no statistical differences were found in the
percentage of BrdU+ cells among the 10, 20 and 40 ng/ml EGF
groups (Figure 2A), indicating that cell proliferation plateaued
at 10 ng/ml. When we grew A2B5+ cells for 7 days, EGF
was found to promote the cell proliferation and survival as
effectively as basic fibroblast growth factor (bFGF), but the
percentages of BrdU+ cells on d3 and d7 in EGF groups
were higher than those of bFGF groups (Figures 2B,C). When
GRP cells were treated with EGF and Erlotinib HCl (an
antagonist of EGFR) simultaneously, the biological effects of
EGF on promoting the division and survival was neutralized
(Figures 2B,C), and the antigenic phenotypes were similar
to those of the control (Figure 4B). T3 did not significantly
enhance the proliferation of A2B5+ cells compared to control
group (Figure 2B), but it significantly reduced cell apoptosis
(Figure 2C), probably by promoting A2B5+ cell differentiation
into OLs (Figures 3D,E).
EGF also cooperated with PDGFaa to promote a vibrant
proliferation of A2B5+ cells as bFGF + PDGFaa did
(Figures 2B,C). As a result, EGF + PDGFaa stimulated A2B5+
cells to divide continuously and form clones (Figures 2B, 3A).
Three randomly chosen primary clones (EGF + PDGFaa
treatment) were digested into single cells with trypsin and
replated for antigen phenotyping and differentiation potential
analysis. All clones from the freshly immunopurified A2B5+
cells expressed the same antigens as described above. Cells
grown in the presence of cholinergic neurotrophic factor
(CNTF) and bFGF mainly yielded A2B5+/GFAP+ type II
astrocytes, but A2B5−/GFAP+ type I astrocytes in the presence
of FBS (Figures 3B,C). When exposed to thyroid hormone
T3 (Rodríguez-Peña, 1999) for 5 days, all clones gave rise to
MBP+ mature OLs with multiple interconnecting processes
(Figures 3D,E; Shaw et al., 1981). No neurofilament+ neurons
were generated in these cultures. Thus, these A2B5+ cells are the
bona fide tripotential glial progenitor cells (GRP cells), with the
potential to generate OLs and two distinct types of astrocytes
(Gregori et al., 2002; Dadsetan et al., 2009; Haas et al., 2012).
Recloning experiments showed EGF and PDGFaa have a
synergistic effect on the extensive self-renewal of GRP cells.
After primary clones were amplified in EGF + PDGFaa for
10 days, randomly selected clones were digested into single
cells and evenly plated at clonal density on three separate grid
dishes, and then cultured in the presence of EGF, PDGFaa, or
both. EGF and PDGFaa treatment yielded an average of 21 and
6 secondary clones, respectively. When these two factors were
added together, the number of secondary clones reached an
average of 51, far greater than the sum of individual factors
(Figure 2D), suggesting that EGF synergized with PDGFaa
in stimulating the clonal expansion of GRP cells. Secondary
clones exhibited an identical pattern of antigen expressions to
primary clones and can differentiate into MBP+ OLs, A2B5+
or A2B5− astrocytes under corresponding environmental cues.
Based on these observations, it is concluded that EGF signaling
participated in the survival and extensive self-renewal of GRP
cells.
EGF Promoted the Generation of
Early-Stage OPCs from GRP Clones
Tripotential GRP cells are capable of developing into bipotential
OPCs under appropriate signals (Gregori et al., 2002). To
investigate how EGF signaling influences this transition process,
we grew freshly immunopurified GRP cells at clonal density on
48-well plates for 5 days in the presence or absence of EGF,
and then analyzed the formation of OPCs from a single GRP
cell by tracking clonal differentiation (Figure 4A) as described
previously (Gregori et al., 2002). Since common GRP markers
such as A2B5, Olig2, PDGFRα and Nestin were also positive for
OPCs (Crang et al., 2004; Yang et al., 2016), only O4 monoclonal
antibody can be used to define a secondary stage of OPC
development (Sommer and Schachner, 1981; Chen et al., 2007;
Dincman et al., 2012). In EGF group, 10.7% ± 1.3% of the
clones generated O4+/MBP− cells (Figures 4A,B). While in
the control group, GRP cells were unable to divide to form
clones due to the lack of growth factors, so only a few single
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FIGURE 1 | The antigenic phenotypes of E13.5 spinal cord derived A2B5+ cells. (A–P) Immunostaining of A2B5+ cells with PDGFRα, epidermal growth factor
receptor (EGFR), Olig2 and Nestin antibodies, respectively, and the antigenic phenotypes were confirmed by Western blotting (D,H,L,P). (Q) Quantification of
PDGFRα+, EGFR+, Olig2+, Nestin+, GFAP+ and NF-1+ cells in A2B5+ cell cultures, n = 3. Scale bars: 50 µm.
O4+/MBP− cells (1.3% + 0.3%) were observed (Figure 4B). The
specificity of EGF signaling in promoting oligodendrogenesis
was confirmed with Erlotinib HCl. When GRP cells were treated
with EGF and Erlotinib HCl simultaneously, the antigenic
phenotypes were similar to those of the controls (Figure 4B).
Based on these results, we postulated that EGF plays a modest
role in promoting the development of GRP cells into OPCs.
However, it is plausible that a considerable number of clones
have differentiated into O4− early-stage OPCs that could not
be detected immunologically. To examine this possibility, we
continued to culture these single GRP cell derived clones in glial
basal medium for another 5 days in the absence of EGF. In
the control group, only 1.5% ± 0.2% of the cells were MBP+
(Figure 4D), similar to the percentage of O4+ clones prior to the
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FIGURE 2 | Effect of EGF on A2B5+ cells. (A) Histogram of the number of
BrdU+ cells found in A2B5+ cell cultures after exposure to different doses of
EGF. ∗ Indicates differences between groups 10, 20 and 40 ng/ml EGF vs. the
low-dose groups, P < 0.05. No differences were found among the groups of
10, 20 and 40 ng/ml. n = 3. (B,C) Quantification of BrdU+ and TUNEL+ cells
in A2B5+ cell cultures after EGF, EGF + Erlotinib-HCl, basic fibroblast growth
factor (bFGF), PDGFaa, T3, bFGF + PDGFaa and EGF + PDGFaa treatments
for various time lengths, Ctrl refers to the groups without any supplemented
factor, n = 3. (D) Histogram of the number of secondary clones in A2B5+ cell
cultures at clonal density after exposure to EGF, PDGFaa and EGF + PDGFaa,
respectively. n = 3. Statistical analyses are presented as mean ± SD.
∗P < 0.05, ∗∗P < 0.01.
5-day culture (Figure 4B). In the EGF group, 32.4% ± 2.7% of
the clones generated MBP+ cells (Figures 4C,D), suggesting that
about 21.4% (32.4% MBP+–10.7% O4+MBP−) of the clones in
EGF group generated O4− OPCs. Thus, EGF predisposed GRP
cells to develop along OPCs.
However, EGF treatment alone was less efficient in fully
transforming GRP cells into OPCs and maintaining their
O4 negative antigen phenotype. We found that GRP cells
exposed to a combination of EGF + PDGFaa + T3 exhibited
a significant change from fibroblast morphology to bipolar
or tripolar morphology, and remained O4 negative antigen
phenotype. Moreover, the vast majority of clones (89.1%± 3.7%)
generated O4+/MBP+ OLs after growth factor withdrawal. This
conjecture was further strengthened by their differentiation into
A2B5+/GFAP+ instead of A2B5−/GFAP+ astrocytes upon FBS
treatment (Figure 4E), a bipotential differentiation characteristic
of OPCs (Sommer and Schachner, 1981; Barnett et al., 1993).
EGF Enhances the Self-Renewal of OPCs
PDGFaa is an important mitogen for the self-renewal of OPCs
(Noble et al., 1988; Raff et al., 1988; Hart et al., 1989; Neman and
de Vellis, 2012), but it alone cannot maintain the O4 negative
antigenic phenotype in OPCs. When GRP-derived early-stage
O4− OPCs from EGF + PDGFaa + T3 treatment were cultured
in PDGFaa alone for 5 days, most cells became O4 positive
(88.7%± 5.9%; Figure 5A) but MBP negative with few processes.
FIGURE 3 | Expanded clones of A2B5+ cell expressed typical
differentiation phenotype of tripotential glial restricted precursor
(GRP) cells. (A) An example of an expanded clone in presence of EGF +
PDGFaa. (B) A2B5+ clones were digested and replated into separate wells of
24-well plates and induced to differentiate for 5 days in the presence of
bFGF + CNTF or FBS, A2B5+/GFAP+ and A2B5−/GFAP+ astrocytes were
obtained, respectively. (C) Quantification of A2B5+/GFAP+ and
A2B5−/GFAP+ astrocytes in the differentiation cultures exposed to bFGF +
CNTF and FBS, n = 3. (D) A2B5+ cells were cultured in T3 for 5 days and
MBP+ Oligodendrocytes (OLs) can be detected. (E) The culture described in
(D) was confirmed by western blotting with MBP antibody. Abbreviation: OL,
oligodendrocyte. ∗∗P < 0.01. Scale bars: (A) 100 µm; (B,D) 50 µm.
These O4+ late-stage OPCs (Sommer and Schachner, 1981;
Gard and Pfeiffer, 1990) continued to cycle (Figures 5A,C).
When EGF was present, the majority of cells maintained bipolar
or tripolar morphology, and the rate of O4+ cells decreased
substantially (7.4% ± 2.6%) with a significant increase of
BrdU+ cells (80% ± 3.8%; Figures 5A,B). Moreover, these
expanded cultures of OPCs maintained by EGF + PDGFaa can
differentiate into either mature OLs or A2B5+/GFAP+ astrocytes
under specific culture conditions, indicating the differentiation
potential was not compromised by proliferation, nor did they
revert to GRP cells. Therefore, EGF have a synergistic effect
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FIGURE 4 | EGF enhanced the formation of OPCs from GRP clones.
(A) The single cell tracking of a GRP cell generating O4+/MBP− daughter cells
in EGF for 5 days. With the progression of cell division, a fibroblast-like GRP
cell was gradually converted to typical OPCs of bipolar or tripolar morphology,
well separated from each other, and expressed O4 antigen but not MBP.
Daughter cells of the same progenitor were indicated by arrows of different
color. (B) Quantification of the clones containing O4+/MBP− cells in the GRP
cell cultures exposed to various combinations of factors for 5 days,
respectively, n = 3. (C) OPC-like cells from (B) differentiated into MBP+ cells
after 5 days of culture in glial basal medium without supplemented factors.
Left: phase image; right: anti-MBP immunostaining. (D) Quantification of the
clones containing MBP+ cells in OL differentiation cultures described in (C),
n = 3. (E) OPCs derived from EGF + PDGFaa + T3 treament differentiated into
A2B5+/GFAP+ astrocytes in presence of FBS. ∗P < 0.05. Scale bars: (A,C)
75 µm; (E) 50 µm.
with PDGFaa in the self-renewal of O4− OPCs. And this
cooperative effect of EGF and PDGFaa can be further amplified
by other growth factor such as bFGF. When GRP-derived early-
stage O4− OPCs were cultured in EGF + PDGFaa + bFGF
in vitro, a faster cell division (87.3% ± 4.1%) and less O4+
cells (2.6% ± 0.9%) were observed without compromising their
differentiation characteristics, suggesting that the proliferation
and self-renewal of OPCs are regulated by multiple signaling
pathways.
EGF Treatment Increased the Number of
Differentiated OLs
When GRP-derived O4− OPCs were cultured in EGF alone,
cells were initially active in proliferation, and many more
BrdU-positive cells were found in EGF group than in control
FIGURE 5 | Synergistic effect of PDGFaa and EGF in promoting the
self-renewal of O4− OPCs. (A) Representative images of O4+ and/or
BrdU+ cells cultured in PDGFaa or PDGFaa + EGF for 5 days, cell proliferation
was analyzed by BrdU incorporation for 24 h before fixation. (B) Quantification
of O4+ cells in PDGFaa and PDGFaa + EGF cultures. (C) Quantification of
BrdU+ cells in PDGFaa and PDGFaa + EGF cultures. Statistical analyses are
presented as mean ± SD, n = 3. ∗P < 0.05, ∗∗P < 0.01, Scale bars: 100 µm.
group. However, the percentage of BrdU+ cells in EGF group
decreased with time, and by day 4, less than 3% of cells
were proliferative (Figure 6A). Consistent with this, the EGFR
expression was reduced more than half by day 4 (Figures 6D,E),
which may partly contribute to the reduced effect of EGF on
cell proliferation. It was found that bFGF cannot substitute for
the loss of EGFR (data not shown), and the promotion of OPC
proliferation by EGF or bFGF were based on the existence of
PDGFaa. The reduced cell proliferation was accompanied by
the increased proportion of MBP+ cells in culture (Figure 6B).
Although the rate of OPC differentiation under EGF treatment
was slightly lower than that of control and T3 groups at the
beginning, it increased rapidly on day 3 and exceeded the
other two groups (Figure 6B), suggesting that EGF has a
significant effect in promoting OL maturation when PDGFaa is
not present. A synergistic effect was observed when T3 and EGF
was combined, the differentiation was faster and the efficiency
was higher than that of T3 alone or EGF alone (Figure 6B).
TUNEL labeling experiments revealed that the rate of apoptosis
with EGF treatment was significantly lower than that of the
other two groups (Figure 6C). This raised the possibility that
EGF treatment may partly increase the number of mature OLs
indirectly by promoting their post-mitotic survival.
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FIGURE 6 | EGF promotes OPC differentiation in cooperation with T3. (A) Quantification of BrdU+ cells for OPCs cultures with EGF or not for various time
lengths. (B) Quantification of MBP+ cells in OPCs differentiation cultures treated with T3, EGF or T3 + EGF for various time lengths. (C) Quantification of TUNEL+
cells in OPCs differentiation cultures on day 4. (D,E) Western blotting and quantitative analysis of EGFR protein expression in O4− OPCs and MBP+ OLs, histograms
express results in arbitrary units, taking GRP cells values as 100%. Statistical analyses are presented as mean ± SD, n = 3. ∗P < 0.05, ∗∗P < 0.01.
DISCUSSION
EGF is an extracellular signal molecule that binds to its specific
receptor (EGFR) on the target cell membrane and then stimulates
the phosphorylation of the receptor. The EGFR, also known as
erbB1, is a glycoprotein that belongs to the related proteins family
of c-erbB, there are three other members of this family: erbB2,
erbB3 and erbB4 (Galvez-Contreras et al., 2013). The EGFR
can generate homodimerization or heterodimerization with all
ErbB family members, therefore, activated EGFR can stimulate
a large number of downstream signaling molecules, and the
complexity of its signal transduction determines the diversity of
its biological effects. The diversity of EGF biological effects is
reflected in the progression of OL lineage, as it plays distinct roles
at different stages of OL development (Figure 7). The biological
diversity of EGF signaling could be achieved by changing the
balance between different signaling pathways (Tzahar et al.,
1996).
Role of EGF Signaling in GRP Development
GRP cells are probably the earliest progenitor cells for OL
and astrocyte lineages (Rao et al., 1998; Gregori et al., 2002).
GRP cells exhibited strong responsiveness to EGF for cell
survival and proliferation in chemically defined medium. This
result suggests that EGF signaling may be involved in the
origin and expansion of GRP cells. Consistent with this
idea, EGFR overexpression in postnatal white matter led to
diffuse hyperplasia of progenitor cells that possess the same
antigen phenotype as GRP cells in vitro (Ivkovic et al., 2008).
FIGURE 7 | Biological effects of EGF, PDGFaa, bFGF and T3 in the
progression of OL lineage. EGF has multiple biological effects on
oligodendrogenesis, and its functional output is influenced by other signal
molecules, such as PDGFaa and T3. In GRP cells, EGF and bFGF collaborate
with PDGFaa to promote the self-renewal of GRP cells. When EGF is present
alone, it favors the development of GRP cells to OPCs, and this progress is
accelerated by supplementing PDGFaa and T3 simultaneously. In OPCs, EGF
and bFGF enhance their responsiveness to PDGFaa and thus maintains their
O4 negative phenotype as well as bipolar or tripolar cell morphology. When
EGF is present alone, it synergizes with T3 to promote the terminal
differentiation of OPCs, whereas bFGF and PDGFaa inhibit this differentiation
process.
Moreover, following lysolecithin (LPC)-induced demyelination,
a significantly higher number of GRP cells was observed in
EGFR-overexpressing transgenic mice than that of the wild-type,
leading to faster and more extensive remyelination, and more
rapid functional recovery. Conversely, reduced EGFR signaling
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in vivo decreased the generation of OLs in postnatal brains
(Aguirre et al., 2007).
EGF has a variety of biological effects on GRP cells,
including cell survival and proliferation, and enhanced OL
lineage progression. However, its eventual functional output is
influenced by other signal molecules. For instance, PDGFaa
and EGF work synergistically to maintain the self-renewal, the
rate of cell proliferation decreased substantially after PDGFaa
withdrawal, and GRP cells progressed into OPCs. The number
of secondary clones in EGF group was much lower than that of
PDGFaa + EGF group, probably due to the higher differentiation
rate in the EGF group, and thus the reduced ability of GRP cells
to form clones.
Role of EGF Signaling in OPC Lineage
Development
OPCs retained strong responsiveness to EGF, and EGF enhanced
the response of early-stage OPCs to PDGFaa in their self-renewal.
In the absence of EGF, PDGFaa alone was difficult to prevent
OPCs from expressing O4 antigen, and the cells then entered the
secondary stage of OPC development with reduced proliferative
capacity. The mechanisms underlying this enhanced response is
not clear, one possibility is that it may function tomaintain a high
level of PDGFRα expression or signaling in OPCs (McKinnon
et al., 1990). Thus, EGF may ‘‘set’’ a PDGF-driven clock in OPCs
by establishing their sensitivity to PDGFaa (Galvez-Contreras
et al., 2013). In this way, EGF may enlarge the OPC pool during
CNS development.
The biological effect of EGF in promoting oligodendrogenesis
was also reflected in the maturation of OPCs into OLs. EGF alone
could not maintain the self-renewal of OPCs; instead it appeared
to promote the differentiation of OPCs and the survival ofmature
OLs (Figure 6), leading to an increased number of MBP+ mature
OLs.
Comparison of EGF and bFGF Effects in
Oligodendroglial Lineage Development
bFGF was commonly used in GRP cell culture, and it alone
was sufficient to maintain the self-renewal of GRP cells in vitro
(Gregori et al., 2002). Similarly, bFGF was also widely used in
OPC culture to suppress OPC differentiation and myelin gene
expression (McKinnon et al., 1990; Bansal and Pfeiffer, 1997;
Decker et al., 2000; Jiang et al., 2001). Thus, it seems that bFGF
promotes progenitor maintenance by preventing the lineage
progression of both GRP and OPC cells.
The present study has demonstrated that EGF is also effective
in the maintenance of GRP and OPC culture. However, EGF
appears to enhance the self-renewal of GRPs and OPCs by
enhancing their responses to PDGFRα instead of directly
inhibiting their differentiation. As a matter of fact, EGF
treatment alone promotes the differentiation of both GRP cells
and OPCs in culture. In the absence of PDGFaa and bFGF,
EGF enhances GRP lineage progression to OPCs and OPC
differentiation to mature OLs in synergy with T3 (Figure 7).
Therefore, EGF and bFGF possess unique and distinct roles
in oligodendroglial progenitor self-renewal and differentiation.
Consistent with this notion, bFGF−/− knockout leads to a higher
proportion of mature OLs (Murtie et al., 2005), whereas EGFR
mutation reduces the number of mature OLs (Aguirre et al.,
2007).
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